Vivos Therapeutics (VVOS) Q4 2025 Earnings

19NovConfirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
-0.66
-0.56
-0.47
-0.38

Details

Expected EPS
-0.51
Actual EPS
-0.49
Surprise EPS
0.02
Surprise Percent
+3.92%

Description

Vivos Therapeutics (VVOS) has reported earnings of -0.49 per share for Q4 2025.

0 Comments

Share your thoughts